NanoViricides, Inc. (NASDAQ:NNVC)

PRESS RELEASE

published on 05/20/2024 at 12:30, 1 year 10 months ago

Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection

NV-387 Clinical Trials NanoViricides Inc. Antiviral RSV
BRIEF

published on 05/15/2024 at 12:35, 1 year 10 months ago

NanoViricides Reports Financial Update and Advancements in Clinical Trials

NanoViricides NV-387 Financial Report Clinical Trials Antiviral Treatment
BRIEF

published on 05/15/2024 at 12:35, 1 year 10 months ago

NanoViricides annonce une mise à jour financière et des progrès dans les essais cliniques

NanoViricides NV-387 Rapport Financier Essais Cliniques Traitement Antiviral
PRESS RELEASE

published on 05/15/2024 at 12:30, 1 year 10 months ago

NanoViricides Has Filed its Quarterly Report
NanoViricides, Inc. reports advancing NV-387 to Phase II Clinical Trial for RSV infection treatment. Financial status and future plans discussed

NV-387 Phase II Clinical Trial NanoViricides Inc. RSV Infection Antiviral Nanomedicines
BRIEF

published on 05/14/2024 at 12:35, 1 year 10 months ago

NanoViricides Announces Breakthrough in RSV Treatment with NV-387

NanoViricides NV-387 Pharmaceutical Innovation RSV Treatment Antiviral Research
BRIEF

published on 05/14/2024 at 12:35, 1 year 10 months ago

NanoViricides annonce une percée dans le traitement du VRS avec le NV-387

NanoViricides NV-387 Innovation Pharmaceutique Traitement Contre Le VRS Recherche Antivirale
PRESS RELEASE

published on 05/14/2024 at 12:30, 1 year 10 months ago

A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides, Inc. announces complete survival of animals lethally infected with RSV in lungs upon NV-387 oral treatment. Promising antiviral activity shown in study

NV-387 NanoViricides Inc. Antiviral Treatment RSV Infection Lung Infection
BRIEF

published on 05/08/2024 at 12:35, 1 year 10 months ago

NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox

NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF

published on 05/08/2024 at 12:35, 1 year 10 months ago

NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox

NanoViricides NV-387 Tecovirimat Variole Mvariole
PRESS RELEASE

published on 05/08/2024 at 12:30, 1 year 10 months ago

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides reports NV-387 shows strong orthopoxvirus activity against Smallpox/Mpox via inhalation and skin transmission. Study highlights efficacy in lethal animal models, supporting clinical development potential

NanoViricides NV-387 Clinical Development Orthopoxvirus Antiviral

Published on 03/26/2026 at 13:00, 1 hour ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 1 hour ago

GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 1 hour 1 minute ago

Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 1 hour 15 minutes ago

Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 1 hour 15 minutes ago

Electric Royalties Provides Update on Critical Metals Royalty Portfolio

View all ACCESSWIRE

Published on 03/26/2026 at 13:47, 13 minutes ago

EQS-Adhoc: Ping An Insurance (Group) Company of China, Ltd.: PROPOSED DISTRIBUTION OF FINAL DIVIDEND
Published on 03/26/2026 at 13:00, 1 hour ago

AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
Published on 03/26/2026 at 13:00, 1 hour ago

Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI
Published on 03/26/2026 at 12:45, 1 hour 15 minutes ago

Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 1 hour 40 minutes ago

North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million

View all EQS

Published on 03/26/2026 at 08:57, 5 hours 3 minutes ago

Communiqué Edenred
Published on 03/26/2026 at 08:57, 5 hours 3 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 6 hours 30 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 6 hours 30 minutes ago

BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 19 hours 7 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026

View all LES ECHOS COMFI WIRE

News